deltatrials
Recruiting NCT00488878

Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors

Data Collection for Patients With Low Grade Ovarian Carcinoma

Sponsor: M.D. Anderson Cancer Center

Updated 21 times since 2017 Last updated: Feb 11, 2026 Started: May 19, 2006 Primary completion: May 1, 2034 Completion: May 1, 2035

A observational or N/A phase clinical study on Low Grade Ovarian Serous Adenocarcinoma and Malignant Ovarian Neoplasm, this trial is actively recruiting participants. The trial is conducted by M.D. Anderson Cancer Center and has accumulated 21 data snapshots since 2006. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Change History

21 versions recorded
  1. Feb 2026 — Present [monthly]

    Recruiting

  2. Sep 2025 — Feb 2026 [monthly]

    Recruiting

  3. Mar 2025 — Sep 2025 [monthly]

    Recruiting

  4. Sep 2024 — Mar 2025 [monthly]

    Recruiting

  5. Jul 2024 — Sep 2024 [monthly]

    Recruiting

Show 16 earlier versions
  1. Mar 2024 — Jul 2024 [monthly]

    Recruiting

  2. Sep 2023 — Mar 2024 [monthly]

    Recruiting

  3. Mar 2023 — Sep 2023 [monthly]

    Recruiting

  4. Sep 2022 — Mar 2023 [monthly]

    Recruiting

  5. Dec 2021 — Sep 2022 [monthly]

    Recruiting

  6. Mar 2021 — Dec 2021 [monthly]

    Recruiting

  7. Jan 2021 — Mar 2021 [monthly]

    Recruiting

  8. Nov 2020 — Jan 2021 [monthly]

    Recruiting

  9. Jun 2019 — Nov 2020 [monthly]

    Recruiting

  10. Sep 2018 — Jun 2019 [monthly]

    Recruiting

  11. Jun 2018 — Sep 2018 [monthly]

    Recruiting

  12. May 2018 — Jun 2018 [monthly]

    Recruiting

  13. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NANone

  14. Sep 2017 — Apr 2018 [monthly]

    Recruiting NA

  15. Aug 2017 — Sep 2017 [monthly]

    Recruiting NA

  16. Jan 2017 — Aug 2017 [monthly]

    Recruiting NA

    First recorded

May 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • M.D. Anderson Cancer Center
Data source: M.D. Anderson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • Houston, United States